Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape

The quest for treatment-free remission (TFR) and deep molecular response (DMR) in chronic myeloid leukemia (CML) has been profoundly impacted by tyrosine kinase inhibitors (TKIs). Immunologic surveillance of residual leukemic cells is hypothesized to be one of the critical factors in successful TFR,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Ya-Ching, Kirschner, Kristina, Copland, Mhairi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102187/
https://www.ncbi.nlm.nih.gov/pubmed/33833387
http://dx.doi.org/10.1038/s41375-021-01238-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102187/
https://www.ncbi.nlm.nih.gov/pubmed/33833387
http://dx.doi.org/10.1038/s41375-021-01238-w

Ejemplares similares